Monday, August 31, 2026

U.S. Bancorp Stock Over 10% Down At Session Start Today

U.S. Bancorp Stock Over 10% Down At Session Start Today

(VIANEWS) - Shares of U.S. Bancorp (NYSE: USB) dropped by a staggering 10.73% to $36.26 at 10:25 EST on Monday, after five successive sessions in a row of losses. NYSE is falling 0.78% to $14,778.26, after two successive sessions in a row of losses. This seems, as yet, a somewhat down trend trading session today.

U.S. Bancorp's last close was $40.62, 29.87% below its 52-week high of $57.92.

About U.S. Bancorp

U.S. Bancorp, a financial services holding company, provides various financial services to individuals, businesses, institutional organizations, governmental entities and other financial institutions in the United States. It operates in Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support segments. The company offers depository services, including checking accounts, savings accounts, and time certificate contracts; lending services, such as traditional credit products; and credit card services, lease financing and import/export trade, asset-backed lending, agricultural finance, and other products. It also provides ancillary services comprising capital markets, treasury management, and receivable lock-box collection services to corporate and governmental entity customers; and a range of asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations. In addition, the company offers investment and insurance products to its customers principally within its markets, as well as fund administration services to a range of mutual and other funds. Further, it provides corporate and purchasing card, and corporate trust services; and merchant processing services, as well as investment management, ATM processing, mortgage banking, insurance, and brokerage and leasing services. The company was founded in 1863 and is headquartered in Minneapolis, Minnesota.

Earnings Per Share

As for profitability, U.S. Bancorp has a trailing twelve months EPS of $3.79.

PE Ratio

U.S. Bancorp has a trailing twelve months price to earnings ratio of 9.57. Meaning, the purchaser of the share is investing $9.57 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.95%.

Volume

Today's last reported volume for U.S. Bancorp is 8553102 which is 3.45% above its average volume of 8267690.

Sales Growth

U.S. Bancorp's sales growth is 29% for the current quarter and 22.9% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 3.91%.

Moving Average

U.S. Bancorp's worth is way below its 50-day moving average of $47.17 and way under its 200-day moving average of $45.80.

More news about U.S. Bancorp (USB).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com